查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017769

腸外營養市場規模、佔有率和趨勢分析報告：按營養素、給藥階段、適應症、銷售管道、地區和細分市場預測（2026-2033 年）

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type, By Stage Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

腸外營養市場概述

2025年全球腸外營養市場規模估計為79.7億美元，預計2033年將達到125.9億美元。

預計從2026年到2033年，其複合年成長率將達到5.87%。這一成長歸因於胃腸道疾病盛行率的上升、早產兒數量的增加以及癌症等慢性疾病發生率的上升。

醫院基礎設施的擴建、營養配方技術的進步以及居家腸外營養的日益普及，進一步推動了全球市場成長。此外，慢性疾病（尤其是癌症和疾病相關營養不良）的盛行率上升，也推動了對腸外營養的需求。這些患者常出現胃腸功能障礙或治療相關併發症，限制了口服或經腸營養。癌症治療，例如化療和放射線治療，通常需要靜脈營養支持。例如，美國國家癌症研究所 (NCI) 估計，到 2026 年，美國將新增 2,114,850 例癌症病例，並有 626,140 例癌症相關死亡病例，這凸顯了需要腸外營養的患者群體日益成長。

腸外營養具有諸多優勢，包括使用方便、改善胃部血流、高效輸送營養物質、抑制肌肉分解代謝。在全球範圍內，各種以營養為重點的健康意識宣傳活動以及旨在促進健康和社會福祉的各項舉措正在進行，預計這些都將推動市場成長。例如，印度於2023年9月啟動了「營養月」（POSHAN Maah）。這體現了印度政府的旗艦計畫「營養運動」（POSHAN Abhiyaan），該計畫旨在意識提升，並改善他們的營養狀況。

營養支持療法（PN）也適用於患有疾病或健康問題、需要特殊營養管理的嬰兒童。 2023年，歐洲特殊營養協會（SNE）估計，歐盟約有30萬名兒童需要醫療營養，以滿足嬰幼兒早期的特殊醫療需求，並支持其生長發育。此外，同一項研究發現，約40%的住院成年患者存在營養不良，需要醫療營養來控制疾病相關的營養不良並縮短住院時間。為了降低感染疾病風險和發育不良，PN正在全球越來越廣泛的應用。

為了提高安全性、效率和臨床療效，腸外營養供應商越來越重視即用型多腔輸液袋、先進的脂肪乳劑和病患特異性配方。百特和費森尤斯卡比等公司提供多種專業解決方案，例如新生兒專用“Numeta”、成人專用“Kabiven”以及富含混合油脂和Omega-3的脂肪乳劑“SMOFlipid/Omegaven”，後者旨在支持代謝功能並減少併發症。隨著產業轉向以規範為主導、以患者為中心的營養管理模式轉變，無論是在醫院還是門診，人們也越來越關注新生兒和兒童的個人化腸外營養、居家腸外營養以及簡化的輸液流程。

許多早產兒出生體重偏低，免疫系統發育不全，面臨嚴重的健康風險。個人和醫療機構都非常關注降低早產相關死亡率，這推動了靜脈注射脂肪乳劑的使用。根據美國疾病管制與預防中心（CDC）的數據顯示，2022年美國的早產率約為10.4%。此外，同期非裔美國女性的早產率約為14.6%。如此高的早產率預計將推動市場擴張。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 腸外營養市場：變數、趨勢與範圍

  • 市場譜系展望
  • 產業特定分析
  • 技術展望
  • 法律規範
  • 市場動態
  • 腸外營養市場分析工具

第4章 腸外營養市場：依營養素類型分類的估算與趨勢分析

  • 按營養素類型分類的市場佔有率分析（2025 年和 2033 年）
  • 腸外營養市場：依營養素類型分類，2021-2033年
  • 碳水化合物
  • 腸外脂肪乳劑
  • 單劑量氨基酸溶液
  • 微量元素
  • 維生素和礦物質

第5章 腸外營養市場：依階段類型分類的估算與趨勢分析

  • 按階段類型分類的市場佔有率分析（2025 年和 2033 年）
  • 腸外營養市場：按階段和類型分類，2021-2033年
  • 成人
  • 兒童

第6章 腸外營養市場：依適應症分類的估計與趨勢分析

  • 按適應症分類的市場佔有率分析，2025 年和 2033 年
  • 腸外營養市場：依適應症分類，2021-2033年
  • 阿茲海默症
  • 營養缺乏
  • 癌症治療
  • 糖尿病
  • 慢性腎臟病
  • 罕見疾病
  • 吞嚥困難
  • 疼痛管理
  • 吸收不良/消化系統疾病/腹瀉
  • 其他

第7章 腸外營養市場：依銷售管道分類的估算與趨勢分析

  • 按銷售管道分類的市場佔有率分析（2025 年和 2033 年）
  • 腸外營養市場：依銷售管道分類，2021-2033年
  • 線上
  • 零售
  • 對於醫療機構

第8章 腸外營養市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 區域市場概述
  • 2025 年及 2033 年各地區腸外營養市場展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 南非
    • 科威特

第9章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業市場占有率分析，2025 年
  • Company Position Analysis, 2025
  • 公司簡介
    • Baxter
    • Otsuka Pharmaceutical Factory, Inc.
    • Grifols, SA
    • B. Braun Melsungen AG
    • Vifor Pharma（Acquired by CSL）
    • Fresenius Kabi AG
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Pfizer Inc.（Hospira Inc.）
    • ICU Medical, Inc.
    • JW Pharmaceutical
    • Aculife
Product Code: 978-1-68038-867-1

Parenteral Nutrition Market Summary

The global parenteral nutrition market size was estimated at USD 7.97 billion in 2025 and is projected to reach USD 12.59 billion by 2033, growing at a CAGR of 5.87% from 2026 to 2033. This growth is attributed to the rising prevalence of gastrointestinal disorders, increasing premature births, and the growing incidence of chronic diseases such as cancer.

Expanding hospital infrastructure, advancements in nutrient formulations, and increasing adoption of home parenteral nutrition further support market growth globally. Moreover, the rising prevalence of chronic conditions, particularly cancer and disease-related malnutrition, is driving demand for parenteral nutrition, as these patients often experience gastrointestinal dysfunction or treatment-related complications that limit oral or enteral feeding. Cancer therapies such as chemotherapy and radiation frequently necessitate intravenous nutritional support; for instance, the National Cancer Institute estimates 2,114,850 new cancer cases and 626,140 cancer deaths in the U.S. in 2026, highlighting the growing patient base requiring parenteral nutrition.

Numerous benefits accompany parenteral nutrition, including ease of use, stimulation of stomach blood flow, efficient nutrient delivery, and preservation of muscle catabolism. Globally, various health awareness campaigns, with a particular emphasis on nutrition, are underway, along with diverse initiatives promoting health and social care, expected to bolster market growth. For example, India observed POSHAN Maah in September 2023, mirroring the Government of India's flagship program, POSHAN Abhiyaan, aimed at raising awareness and enhancing nutritional outcomes for pregnant women, children under six years of age, and lactating mothers.

PN also has applications for infants and children suffering from a disease or medical condition, thereby requiring special nutritional management. In 2023, Specialized Nutrition Europe (SNE) estimated that nearly 300,000 EU children are anticipated to require medical nutrition for their special medical needs in early life stages, which supports growth and development. The study further reveals that about 40% of hospitalized adult patients are malnourished and need medical nutrition to manage the disease-related malnutrition condition, thereby reducing the duration of hospital stay. PN lowers the infection risk and underdevelopment, thereby promoting its adoption worldwide.

Parenteral nutrition providers are increasingly focusing on ready-to-use multi-chamber bags, advanced lipid emulsions, and patient-specific formulations to improve safety, efficiency, and clinical outcomes. Companies like Baxter and Fresenius Kabi offer specialized solutions such as Numeta for neonates, Kabiven for adults, and SMOFlipid/Omegaven lipid emulsions enriched with mixed oils and omega-3s to support metabolic function and reduce complications. There is also a growing emphasis on tailored neonatal and pediatric PN, home parenteral nutrition, and streamlined infusion workflows, reflecting the industry's shift toward protocol-driven, patient-centric nutrition management across hospital and outpatient settings.

Many premature babies experience low weight and underdeveloped immunity, placing them at significant risk. There is extensive focus from individuals and healthcare authorities on reducing mortality associated with preterm birth, which drives the utilization of parenteral lipid emulsions. According to the U.S. Centers for Disease Control and Prevention (CDC), the preterm birth rate in the country was approximately 10.4% in 2022. In addition, during the same period, the preterm birth rate for African American women was around 14.6%. These elevated preterm birth rates are expected to bolster market expansion.

Global Parenteral Nutrition Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global parenteral nutrition market report based on nutrient type, stage type, indication, sales channel, and region:

  • Nutrient Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals
  • Stage Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Adult
  • Pediatrics
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Retail
  • Institutional
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • China
    • India
    • Japan
    • Thailand
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Nutrition Type Outlook
    • 2.2.2. Stage Type Outlook
    • 2.2.3. Indication Outlook
    • 2.2.4. Sales Channel Outlook
  • 2.3. Competitive Insights

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising Prevalence of Gastrointestinal Disorders and Malabsorption Conditions
      • 3.5.1.2. Increasing Number of Preterm Births Requiring Neonatal Nutritional Support
      • 3.5.1.3. Growing Incidence of Cancer and Demand for Clinical Nutritional Support
      • 3.5.1.4. Expansion of Home Parenteral Nutrition (HPN) Programs
      • 3.5.1.5. Rising Hospital Admissions and Critical Care Patient Population
      • 3.5.1.6. Increasing Awareness of Clinical Nutrition in Disease Management
      • 3.5.1.7. Growing Geriatric Population with Nutritional Deficiencies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Stringent Regulatory Requirements for Sterile Compounding
      • 3.5.2.2. Risk of Metabolic and Liver-Related Complications
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Parenteral Nutrition Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Nutrient Type Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Parenteral Nutrition Market: By Nutrient Type, 2021 to 2033
  • 4.5. Carbohydrates
    • 4.5.1. Carbohydrates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Parenteral Lipid Emulsion
    • 4.6.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Single Dose Amino Acid Solution
    • 4.7.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Trace Elements
    • 4.8.1. Trace Elements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Vitamins & Minerals
    • 4.9.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Stage Type Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Parenteral Nutrition Market: By Stage Type, 2021 to 2033
  • 5.5. Adult
    • 5.5.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Pediatric
    • 5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Indication Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Parenteral Nutrition Market: By Indication, 2021 to 2033
  • 6.5. Alzheimer's
    • 6.5.1. Alzheimer's Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Nutrition Deficiency
    • 6.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Cancer Care
    • 6.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Diabetes
    • 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Chronic Kidney Disease
    • 6.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Orphan Diseases
    • 6.10.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Dysphagia
    • 6.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Pain Management
    • 6.12.1. Pain Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Malabsorption/GI Disorder/Diarrhea
    • 6.13.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Others
    • 6.14.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. Sales Channel Market Share Analysis, 2025 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Parenteral Nutrition Market: By Sales Channel, 2021 to 2033
  • 7.5. Online
    • 7.5.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Retail
    • 7.6.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Institutional
    • 7.7.1. Institutional Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis by Country, Nutrient Type, Stage Type, Indication, and Sales Channel

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2025 & 2033
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. Parenteral Nutrition Market Share, By Region, 2025 & 2033 (USD Million)
  • 8.6. North America
    • 8.6.1. North America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. U.S.
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. U.S. Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Canada
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. Canada Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. Mexico
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. Mexico Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Europe
    • 8.7.1. Europe Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. UK
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. UK Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Germany
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Germany Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. France
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. France Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Italy
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.5.3. Competitive Insights
      • 8.7.5.4. Italy Parenteral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Spain
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.6.3. Competitive Insights
      • 8.7.6.4. Spain Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Sweden
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.7.3. Competitive Insights
      • 8.7.7.4. Sweden Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.8. Denmark
      • 8.7.8.1. Key Country Dynamics
      • 8.7.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.8.3. Competitive Insights
      • 8.7.8.4. Denmark Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.9. Norway
      • 8.7.9.1. Key Country Dynamics
      • 8.7.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.9.3. Competitive Insights
      • 8.7.9.4. Norway Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Asia Pacific Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. China
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. China Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Japan
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Japan Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. India
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. India Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. South Korea
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. South Korea Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.6. Australia
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Australia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.7. Thailand
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Thailand Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Latin America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.9.2. Brazil
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. Brazil Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.9.3. Argentina
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Argentina Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.10. Middle East and Africa
    • 8.10.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.2. Saudi Arabia
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.3. UAE
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. UAE Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.4. South Africa
      • 8.10.4.1. Key Country Dynamics
      • 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.10.5. Kuwait
      • 8.10.5.1. Key Country Dynamics
      • 8.10.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.5.3. Competitive Insights
      • 8.10.5.4. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Position Analysis, 2025
  • 9.5. Company Profiles
    • 9.5.1. Baxter
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Otsuka Pharmaceutical Factory, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Grifols, S.A.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. B. Braun Melsungen AG
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma (Acquired by CSL)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Fresenius Kabi AG
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Sichuan Kelun Pharmaceutical Co., Ltd.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Pfizer Inc. (Hospira Inc.)
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. ICU Medical, Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. JW Pharmaceutical
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Aculife
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 4 North America Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 5 North America Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 6 North America Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 7 U.S. Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 8 U.S. Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 9 U.S. Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 10 U.S. Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 11 Canada Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 12 Canada Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 13 Canada Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 14 Canada Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 15 Mexico Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 16 Mexico Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 18 Mexico Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 19 Europe Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 20 Europe Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 21 Europe Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 22 Europe Parenteral nutrition market estimates and forecasts by sales channel, 2021 - 2033 (USD Million)
  • Table 23 UK Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 24 UK Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 25 UK Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 26 UK Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 27 Germany Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 28 Germany Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 29 Germany Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 30 Germany Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 31 France Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 32 France Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 33 France Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 34 France Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 35 Italy Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 36 Italy Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 37 Italy Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 38 Italy Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 39 Spain Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 40 Spain Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 41 Spain Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 42 Spain Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 43 Sweden Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 44 Sweden Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 45 Sweden Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 46 Sweden Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 47 Denmark Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 48 Denmark Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 49 Denmark Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 50 Denmark Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 51 Norway Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 52 Norway Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 53 Norway Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 54 Norway Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 59 Japan Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 60 Japan Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 61 Japan Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 62 Japan Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 63 China Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 64 China Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 65 China Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 66 China Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 67 India Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 68 India Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 69 India Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 70 India Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 71 Australia Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 72 Australia Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 73 Australia Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 74 Australia Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 75 South Korea Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 76 South Korea Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 77 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 78 South Korea Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 79 Thailand Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 80 Thailand Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 81 Thailand Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 82 Thailand Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 83 Latin America Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 84 Latin America Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 85 Latin America Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 86 Latin America Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 87 Brazil Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 88 Brazil Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 89 Brazil Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 90 Brazil Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 91 Argentina Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 92 Argentina Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 93 Argentina Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 94 Argentina Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 95 MEA Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 96 MEA Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 97 MEA Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 98 MEA Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 99 South Africa Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 100 South Africa Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 101 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 102 South Africa Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 103 Saudi Arabia Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 104 Saudi Arabia Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 105 Saudi Arabia Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 106 Saudi Arabia Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 107 UAE Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 108 UAE Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 109 UAE Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 110 UAE Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)
  • Table 111 Kuwait Parenteral nutrition market estimates and forecasts, by nutrient type, 2021 - 2033 (USD Million)
  • Table 112 Kuwait Parenteral nutrition market estimates and forecasts, by stage type, 2021 - 2033 (USD Million)
  • Table 113 Kuwait Parenteral nutrition market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 114 Kuwait Parenteral nutrition market estimates and forecasts, by sales channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Parenteral Nutrition Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Parenteral Nutrition- Market Size and Growth Prospects (USD Million)
  • Fig. 12 Parenteral Nutrition Market: Industry Value Chain Analysis
  • Fig. 13 Parenteral Nutrition Market: Market Dynamics
  • Fig. 14 Parenteral Nutrition Market: PORTER's Analysis
  • Fig. 15 Parenteral Nutrition Market: PESTEL Analysis
  • Fig. 16 Parenteral Nutrition Market Share by Nutrient Type 2025 & 2033 (USD Million)
  • Fig. 17 Parenteral Nutrition Market, by Nutrient Type: Market Share, 2025 & 2033
  • Fig. 18 Carbohydrates Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Parenteral Lipid Emulsion Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Single Dose Amino Acid Solution Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Trace Elements Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Vitamins & Minerals Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 23 Parenteral Nutrition Market, By Stage Type: Key Takeaways
  • Fig. 24 Parenteral Nutrition Market, By Stage Type: Market Share, 2025 & 2033
  • Fig. 25 Adult Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Pediatric Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Parenteral Nutrition Market Share by Indication 2025 & 2033 (USD Million)
  • Fig. 28 Parenteral Nutrition Market, by Indication: Market Share, 2025 & 2033
  • Fig. 29 Pediatric Alzheimer's Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Nutrition Deficiency Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Cancer Care Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Diabetes Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Chronic Kidney Disease Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 34 Orphan Disease Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Dysphagia Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Pain Management Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 37 Malabsorption/GI.Disorder/Diarrhea Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates & Forecasts, 2021 - 2033 (USD Million
  • Fig. 39 Parenteral Nutrition Market, by Sales Channel: Key Takeaways
  • Fig. 40 Parenteral Nutrition Market, by Sales Channel: Market Share, 2025 & 2033
  • Fig. 41 Online Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Retail Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Institutional Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Parenteral Nutrition Market Revenue, by Region, 2025 & 2033 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 Regional Marketplace: Key Takeaways
  • Fig. 47 North America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 U.S. Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Canada Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Europe Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 UK Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Germany Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 France Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 ItalyParenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Spain Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Norway Parenteral Nutrition Market Estimates and Forecasts, (2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific Parenteral Nutrition Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 China Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Japan Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 India Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Australia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Mexico Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 MEA Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 UAE Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 South Africa Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key Company Categorization
  • Fig. 77 Company Market Positioning
  • Fig. 78 Key Company Market Share Analysis, 2025
  • Fig. 79 Strategic Framework